Rare diseases
Investigational molecules
Locations
Study of Astegolimab Treatment in Patients with Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
AustriaStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
AustriaStudy on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
AustriaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
AustriaStudy on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides
AustriaStudy on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome
AustriaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
AustriaStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
AustriaWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
AustriaStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
AustriaGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
AustriaLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
